Vingroup (VIC) Establishes Vinsurgical to Develop Surgical Robots
This Aveluro analysis covers VIC (Tập đoàn Vingroup - Công ty Cổ phần) in the Real Estate sector. The classified event type is strategic partnership, with positive sentiment and a deterministic market-impact score of 4.0/10. Aveluro classifies this story as a positive catalyst in the stock's news coverage. Source coverage came from CafeF - Thị trường chứng khoán, classified as a primary/top-tier source.
Follow this event and trade Vietnam stocks
Use the broker guide to compare Vietnam market access before acting on this news.
Aveluro may earn a commission from broker partners. Market data and broker availability can change; confirm access before opening an account.
Overview
Vingroup (VIC) has announced the establishment of a new subsidiary, Vinsurgical, with charter capital of 300 billion VND to research and develop surgical robots and smart medical devices. Vingroup holds a 51% stake in the new company, contributing 153 billion VND. This initiative marks a strategic expansion into advanced medical technology within Vingroup’s existing healthcare and robotics ecosystem.
Key Facts
- Vingroup (VIC) established a new subsidiary, Vinsurgical, with charter capital of 300 billion VND.
- Vingroup holds a 51% stake, contributing 153 billion VND.
- Vinsurgical focuses on research, development, and transfer of surgical robot technology, smart medical devices, and advanced medical support solutions.
- Vingroup’s healthcare ecosystem includes the Vinmec international general hospital system.
- In December 2025, Vingroup dissolved VinMedtech, a high-tech medical investment company.
- Vingroup also owns two robotics subsidiaries: VinRobotic and VinMotion, each with charter capital of 1,000 billion VND and Vingroup holding 51% in each.
- In Q1 2026, Vingroup reported consolidated net revenue of 104,352 billion VND (+24% YoY) and net profit of 5,611 billion VND (+150% YoY).
What Happened
Vingroup’s Board of Directors approved the establishment of Vinsurgical, a new subsidiary dedicated to surgical robotics and smart medical devices. The company will focus on research, development, and technology transfer in these fields. Vingroup holds a 51% stake, with the remaining 49% held by other investors (not disclosed).
This move comes after Vingroup dissolved VinMedtech in December 2025, indicating a strategic pivot within its medical technology investments. Vingroup already operates Vinmec hospitals and has two robotics subsidiaries, VinRobotic and VinMotion, both with 1,000 billion VND charter capital.
Market Context
VIC shares closed at 221,000 VND on May 13, 2026, down 0.45% with volume of 6.456 million shares. The stock has been supported by strong Q1 2026 results, with revenue up 24% and net profit up 150% year-on-year. Vingroup’s expansion into surgical robotics aligns with its broader strategy to diversify beyond real estate into technology and healthcare, sectors that are gaining traction in Vietnam’s stock market.
Strategic Significance
The establishment of Vinsurgical signals Vingroup’s commitment to building a high-tech medical equipment capability, potentially reducing reliance on imports and leveraging its existing hospital network (Vinmec) for clinical testing and adoption. This move also complements its robotics subsidiaries, creating synergies in automation and AI. For long-term investors, this represents a step toward vertical integration in healthcare, though the subsidiary is at an early stage with no disclosed revenue or product timeline.
What to Watch
- Further details on Vinsurgical’s product roadmap and partnerships.
- Integration with Vinmec hospitals for clinical trials and deployment.
- Q2 2026 earnings report for Vingroup to assess initial investment impact.
- Any additional capital injections or strategic investors in Vinsurgical.
- Regulatory approvals for medical devices and robotics in Vietnam.